ECBS 2018 - BS DOCUMENTS

15 November 2018

WHO/BS/2018.2332 Collaborative study to calibrate proposed 3rd WHO IS for Anti-D immunoglobulin WHO/BS/2018.2332 Collaborative study to calibrate proposed 3rd WHO IS for Anti-D immunoglobulin

15 November 2018

WHO/BS/2018.2333 An International Collaborative Study to Establish a WHO International Reference Reagent for CD4 T cell counting WHO/BS/2018.2333 An International Collaborative Study to Establish a WHO International Reference Reagent for CD4 T cell counting

15 November 2018

WHO/BS/2018.2334 International Collaborative Study to Establish the 1st WHO International Reference Panel for HIV-1 p24 antigen and HIV-2 p26 antigen WHO/BS/2018.2334 International Collaborative Study to Establish the 1st WHO International Reference Panel for HIV-1 p24 antigen and HIV-2 p26 antigen

15 November 2018

WHO/BS/2018.2335 International collaborative study to assess the suitability of the candidate 7 th WHO International Standard for rabies vaccine WHO/BS/2018.2335 International collaborative study to assess the suitability of the candidate 7 th WHO International Standard for rabies vaccine

15 November 2018

WHO/BS/2018.2336 Evaluation of Candidate International Standards for Meningococcal Serogroup W and Y Polysaccharides WHO/BS/2018.2336 Evaluation of Candidate International Standards for Meningococcal Serogroup W and Y Polysaccharides

15 November 2018

WHO/BS/2018.2337 Proposal for standardization of methods for von Willebrand factor binding to recombinant Glycoprotein Ib - an International Reference Reagent for VWF:GPIbM and VWF:GPIbR methods WHO/BS/2018.2337 Proposal for standardization of methods for von Willebrand factor binding to recombinant Glycoprotein Ib - an International Reference Reagent for VWF:GPIbM and VWF:GPIbR methods

15 November 2018

WHO/BS/2018.2338 Report on the WHO collaborative study to establish the 1st International Standard for Sabin inactivated polio vaccine (sIPV) WHO/BS/2018.2338 Report on the WHO collaborative study to establish the 1st International Standard for Sabin inactivated polio vaccine (sIPV)

15 November 2018

WHO/BS/2018.2339 WHO International Collaborative Study of the Proposed 2nd WHO IS for Free PSA WHO/BS/2018.2339 WHO International Collaborative Study of the Proposed 2nd WHO IS for Free PSA

15 November 2018

WHO/BS/2018.2340 WHO International Collaborative Study of the Proposed 2nd WHO IS for Total PSA (PSA-ACT + free PSA) WHO/BS/2018.2340 WHO International Collaborative Study of the Proposed 2nd WHO IS for Total PSA (PSA-ACT + free PSA)

15 November 2018

WHO/BS/2018.2341 Proposed WHO 2 nd International Standard Factor V, Plasma (16/374) WHO/BS/2018.2341 Proposed WHO 2 nd International Standard Factor V, Plasma (16/374)

15 November 2018

WHO/BS/2018.2342 Inclusion of Additional Reference Reagents to the Existing WHO International Reference Reagents Collection for Blood Group Genotyping WHO/BS/2018.2342 Inclusion of Additional Reference Reagents to the Existing WHO International Reference Reagents Collection for Blood Group Genotyping

15 November 2018

WHO/BS/2018.2343 Preparation and evaluation of the 2nd WHO International Standard for human immunodeficiency virus 2 (HIV-2) for Nucleic acid AmplificationTechniques (NAT) WHO/BS/2018.2343 Preparation and evaluation of the 2nd WHO International Standard for human immunodeficiency virus 2 (HIV-2) for Nucleic acid AmplificationTechniques (NAT)

15 November 2018

WHO/BS/2018.2344 Accelerated stability study on the proposed WHO third International Standard for Erythromycin WHO/BS/2018.2344 Accelerated stability study on the proposed WHO third International Standard for Erythromycin

15 November 2018

WHO/BS/2018.2344 Collaborative Study for the Establishment of the Third International Standard for Erythromycin WHO/BS/2018.2344 Collaborative Study for the Establishment of the Third International Standard for Erythromycin

15 November 2018

WHO/BS/2018.2345 WHO collaborative study to assess the suitability of the 1 st International Standard for antibody to Zika virus WHO/BS/2018.2345 WHO collaborative study to assess the suitability of the 1 st International Standard for antibody to Zika virus

15 November 2018

WHO/BS/2018.2346 A Collaborative Study to Evaluate the Proposed 1st WHO International Standard for Human Adenovirus (HAdV) DNA for Nucleic Acid Amplification Techniques (NAT) WHO/BS/2018.2346 A Collaborative Study to Evaluate the Proposed 1st WHO International Standard for Human Adenovirus (HAdV) DNA for Nucleic Acid Amplification Techniques (NAT)

15 November 2018

WHO/BS/2018.2347 Proposal for WHO Reference Cell Bank status: Second Replacement Seed stock for MRC-5 cells WHO/BS/2018.2347 Proposal for WHO Reference Cell Bank status: Second Replacement Seed stock for MRC-5 cells